Targeted dual inhibition of c‐Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models
Meghan Grojean(Indiana University South Bend), Niranjan Awasthi(University of Notre Dame)
Cited by 24
Related Papers
Endothelial monocyte activating polypeptide II interferes with VEGF-induced proangiogenic signaling
|Laboratory Investigation|2008|65
Inhibition of the MEK/ERK pathway augments nab-paclitaxel-based chemotherapy effects in preclinical models of pancreatic cancer
|Oncotarget|2017|35
Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II
|Journal of Experimental & Clinical Cancer Research|2013|30
Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer
|BMC Cancer|2011|26
Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy
|Molecular Cancer Therapeutics|2022|6